Patents by Inventor Naomi Tanaka
Naomi Tanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938739Abstract: An ink refill container includes a container main body including an ink storage chamber, an ink outlet-forming portion provided on an end portion of the container main body forming an ink outlet that allows the ink to flow out from the ink storage chamber, and a valve provided in the ink outlet-forming portion configured to openably seal the ink outlet, in which the ink outlet-forming portion includes a positioning portion on an outer side of the ink outlet-forming portion. in which the positioning portion is closer to the container main body than the valve is to the container main body in a central axis direction of the ink outlet, and in which the positioning portion partially abuts against an ink tank when the valve is opened for refilling the ink to the ink tank, to thereby position the valve relative to the ink tank.Type: GrantFiled: March 15, 2023Date of Patent: March 26, 2024Assignee: SEIKO EPSON CORPORATIONInventors: Tadahiro Mizutani, Ryoichi Tanaka, Manabu Akahane, Makoto Kobayashi, Naomi Kimura, Hideki Okumura, Shoma Kudo, Tetsuya Takamoto, Hiroaki Sakai
-
Publication number: 20220144765Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. The present invention provides a pharmaceutical composition containing, as an active ingredient, a compound represented by the following formula, or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and represent a C1-C6 alkyl group or the like, and Ar represents an optionally substituted phenyl group or an optionally substituted thienyl group.Type: ApplicationFiled: January 26, 2022Publication date: May 12, 2022Applicant: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Yuji Nakamura, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Publication number: 20210206716Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. The present invention provides a pharmaceutical composition containing, as an active ingredient, a compound represented by the following formula, or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and represent a C1-C6 alkyl group or the like, and Ar represents an optionally substituted phenyl group or an optionally substituted thienyl group.Type: ApplicationFiled: March 23, 2021Publication date: July 8, 2021Applicant: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Yuji Nakamura, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Patent number: 10968169Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect, and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. The present invention provides a pharmaceutical composition containing, as an active ingredient, a compound represented by the following formula, or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and represent a C1-C6 alkyl group or the like, and Ar represents an optionally substituted phenyl group or an optionally substituted thienyl group.Type: GrantFiled: October 5, 2017Date of Patent: April 6, 2021Assignee: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Yuji Nakamura, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Patent number: 10925848Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect, and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. Provided is a pharmaceutical composition containing, as an active ingredient, a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula (I), R1 and R2 are the same or different, and represent a C1-C6 alkyl group, a halogeno C1-C6 alkyl group or a C3-C6 cycloalkyl group; n represents 0, 1 or 2; each X represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom or the like; and Y represents a hydrogen atom, a C1-C6 alkoxy group, a C3-C6 cycloalkoxy group or a halogeno C1-C6 alkoxy group.Type: GrantFiled: February 20, 2018Date of Patent: February 23, 2021Assignee: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Hiroki Sakai, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Publication number: 20200017439Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect, and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. The present invention provides a pharmaceutical composition containing, as an active ingredient, a compound represented by the following formula, or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and represent a C1-C6 alkyl group or the like, and Ar represents an optionally substituted phenyl group or an optionally substituted thienyl group.Type: ApplicationFiled: October 5, 2017Publication date: January 16, 2020Applicant: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Yuji Nakamura, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Publication number: 20190365688Abstract: An object of the present invention is to find a novel pharmaceutical that has an excellent tryptophanase inhibitory effect, and suppresses worsening of renal function to preserve the kidney by reducing production of indoxyl sulfate in the blood. Provided is a pharmaceutical composition containing, as an active ingredient, a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula (I), R1 and R2 are the same or different, and represent a C1-C6 alkyl group, a halogeno C1-C6 alkyl group or a C3-C6 cycloalkyl group; n represents 0, 1 or 2; each X represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom or the like; and Y represents a hydrogen atom, a C1-C6 alkoxy group, a C3-C6 cycloalkoxy group or a halogeno C1-C6 alkoxy group.Type: ApplicationFiled: February 20, 2018Publication date: December 5, 2019Applicant: Daiichi Sankyo Company, LimitedInventors: Tsuyoshi Soneda, Hiroki Sakai, Koji Matsumoto, Naomi Tanaka, Taichi Fukunaga
-
Publication number: 20180311278Abstract: The problem with which the present invention is concerned is providing a novel pharmaceutical preparation, the restrictions on the administration of which to a patient are more relaxed than those of a conventional spherical carbon adsorbent, which can be simultaneously taken with other drugs and, moreover, which is reduced in dosage. The problem can be solved by a pharmaceutical preparation for oral administration comprising a porous material, wherein a means for exposing a surface of the porous material for the first time in the large intestine or a lower part of the small intestine is provided on the porous material.Type: ApplicationFiled: October 25, 2016Publication date: November 1, 2018Applicant: Daiichi Sankyo Company, LimitedInventors: Koji Matsumoto, Tomomi Yoshitomi, Naomi Tanaka, Kazuhiro Yoshida, Yuji Kasuya, Masaoki Ohya
-
Patent number: 7223098Abstract: An ignition unit promotes the efficiency of assembly because connections on the high voltage output side and the ground side are completed by a single operation, when an ignition electrode part and a main unit are connected together directly. A guide rail of the main unit is insertion-engaged into a slit between clamp pieces of a bracket so that the main unit is mounted onto the bracket. With the insertion engagement, a high voltage output terminal receives therein a high voltage input terminal of a spark plug supported by the bracket, a plate terminal which is a part of the bracket is driven into a ground-side connection terminal, and a convex portion of a projected piece is engaged into an engagement hole, for positioning and slipping-off prevention.Type: GrantFiled: August 4, 2004Date of Patent: May 29, 2007Assignee: Noritz CorporationInventors: Hideya Suyama, Atsushi Yoshimoto, Kozo Uehara, Masaaki Kumon, Satoshi Nakai, Kazuya Kawauchi, Takuji Saiki, Shingo Kimura, Naomi Tanaka
-
Publication number: 20050042564Abstract: An ignition unit promotes the efficiency of assembly because connections on the high voltage output side and the ground side are completed by a single operation, when an ignition electrode part and a main unit are connected together directly. A guide rail of the main unit is insertion-engaged into a slit between clamp pieces of a bracket so that the main unit is mounted onto the bracket. With the insertion engagement, a high voltage output terminal receives therein a high voltage input terminal of a spark plug supported by the bracket, a plate terminal which is a part of the bracket is driven into a ground-side connection terminal, and a convex portion of a projected piece is engaged into an engagement hole, for positioning and slipping-off prevention.Type: ApplicationFiled: August 4, 2004Publication date: February 24, 2005Applicant: NORITZ CORPORATIONInventors: Hideya Suyama, Atsushi Yoshimoto, Kozo Uehara, Masaaki Kumon, Satoshi Nakai, Kazuya Kawauchi, Takuji Saiki, Shingo Kimura, Naomi Tanaka